Earnings results for Sensus Healthcare (NASDAQ:SRTS)
Sensus Healthcare, Inc. is estimated to report earnings on 02/11/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.12. The reported EPS for the same quarter last year was $0.06.
Sensus Healthcare last posted its earnings results on November 5th, 2020. The reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.03. The business earned $1.62 million during the quarter, compared to the consensus estimate of $2.24 million. Sensus Healthcare has generated ($0.10) earnings per share over the last year. Sensus Healthcare has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, February 11th, 2021 based off prior year’s report dates.
Analyst Opinion on Sensus Healthcare (NASDAQ:SRTS)
5 Wall Street analysts have issued ratings and price targets for Sensus Healthcare in the last 12 months. Their average twelve-month price target is $4.38, predicting that the stock has a possible upside of 9.50%. The high price target for SRTS is $6.00 and the low price target for SRTS is $3.00. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of “Buy.”
Sensus Healthcare has received a consensus rating of Buy. The company’s average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings. According to analysts’ consensus price target of $4.38, Sensus Healthcare has a forecasted upside of 9.5% from its current price of $4.00. Sensus Healthcare has only been the subject of 1 research reports in the past 90 days.
Dividend Strength: Sensus Healthcare (NASDAQ:SRTS)
Sensus Healthcare does not currently pay a dividend. Sensus Healthcare does not have a long track record of dividend growth.
Insiders buying/selling: Sensus Healthcare (NASDAQ:SRTS)
In the past three months, Sensus Healthcare insiders have not sold or bought any company stock. Only 29.90% of the stock of Sensus Healthcare is held by insiders. Only 7.69% of the stock of Sensus Healthcare is held by institutions.
Earnings and Valuation of Sensus Healthcare (NASDAQ:SRTS
Earnings for Sensus Healthcare are expected to grow in the coming year, from ($0.60) to ($0.13) per share. The P/E ratio of Sensus Healthcare is -9.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Sensus Healthcare is -9.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Sensus Healthcare has a P/B Ratio of 2.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.
More latest stories: here